New real-world evidence on the MSDA Test published in The Multiple Sclerosis Journal – ET&C. Read the press release.

News & Blog

Catch the latest

Recent Announcements & Press

June 2, 2023

Octave Presents New Data at CMSC Annual Meeting 2023, Adding to Growing Evidence Supporting All Dimensions of its Comprehensive Precision Care Solution for Multiple Sclerosis – Businesswire

March 21, 2023

Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis – Proteomics Clinical Applications

February 25, 2023

Octave Presents Data from Nine Company and Partner Abstracts at ACTRIMS Forum 2023 – Businesswire

Octave Note

Media Library